Clinical Trial Update: S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial S0601 evaluating rituximab plus a chemotherapy regimen followed by bortezomib, then bortezomib alone, in newly diagnosed mantle cell lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Rituxan (rituximab)
• Velcade (bortezomib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-02-05